SALT LAKE CITY, April 2, 2026
Co-Diagnostics, Inc. announced that its joint venture CoMira Diagnostics has received approval to establish a state-of-the-art molecular diagnostics manufacturing facility in Sudair Industrial City, Saudi Arabia, marking a major step in expanding regional diagnostic production capabilities and strengthening global healthcare supply chains. The facility, approved by the Saudi Authority for Industrial Cities and Technology Zones (MODON), is expected to support the localization of advanced PCR-based diagnostic technologies and align with Saudi Arabia’s Vision 2030 strategy to enhance domestic manufacturing and healthcare resilience.
Strategic Facility Expansion Strengthens Diagnostic Manufacturing
The newly approved site in Sudair Industrial City, a key industrial hub in the Riyadh region, will serve as a foundation for building a dedicated manufacturing facility for molecular diagnostic instruments and assays. The facility is designed to meet stringent production and regulatory requirements, ensuring high standards in quality, scalability, and compliance with international manufacturing practices.
By establishing local manufacturing capabilities, CoMira aims to accelerate access to advanced diagnostic solutions across the Middle East and North Africa (MENA), reducing dependency on imports and improving supply chain efficiency. This expansion reflects a broader industry trend toward regional manufacturing hubs that enhance resilience and responsiveness in healthcare systems.
Advancing GMP Compliance and Regulatory Readiness
Advertisement
The planned facility will be developed to align with Good Manufacturing Practice (GMP) standards and regulatory expectations for molecular diagnostics, ensuring consistent production quality and product reliability. Co-Diagnostics’ proprietary PCR platform technology, which supports nucleic acid detection for infectious diseases and other applications, will be central to the facility’s operations, subject to regulatory approvals.
The integration of advanced diagnostic technologies with robust quality systems highlights the importance of compliance-driven manufacturing in the MedTech sector, particularly for products intended for clinical and point-of-care use. Additionally, the project will support government procurement initiatives, where local production and regulatory compliance are increasingly critical selection criteria.
Supporting Healthcare Innovation and Economic Diversification
The CoMira facility aligns with Saudi Arabia’s strategic objective to diversify its economy and strengthen domestic healthcare infrastructure under Vision 2030. By localizing production of molecular diagnostic testing solutions, the initiative is expected to enhance national healthcare preparedness, improve access to innovative technologies, and support rapid response to public health challenges.
Company leadership emphasized that the facility will position CoMira as one of the early domestic manufacturers of advanced diagnostics in the Kingdom, enabling faster delivery of high-quality, scalable testing solutions. This development underscores the growing role of public-private partnerships in driving innovation, manufacturing expansion, and healthcare system resilience on a global scale.
Global Expansion Reflects Growing Demand for Diagnostics
Co-Diagnostics’ expansion into Saudi Arabia highlights the increasing global demand for molecular diagnostics, particularly PCR-based technologies, which have become essential tools in infectious disease detection, genetic testing, and public health surveillance. The company’s strategy to establish a presence in emerging markets reflects a long-term vision to scale its technology platform internationally, while maintaining high standards of quality and regulatory compliance.
As healthcare systems continue to prioritize rapid, accurate diagnostics, investments in localized manufacturing infrastructure are expected to play a critical role in ensuring accessibility and reliability of testing solutions worldwide.
Source: Co-Diagnostics press release
